METHOD FOR ESTIMATING THE RISK OF BLEEDING OF THE UPPER GASTROINTESTINAL TRACT IN PATIENTS WITH STABLE ISCHAEMIC HEART DISEASE Russian patent published in 2022 - IPC A61B1/273 A61B8/08 A61B5/205 

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine and can be used in cardiology, gastroenterology and therapy in order to assess the long-term risk of massive and clinically significant bleeding of the upper gastrointestinal tract in outpatient and hospitalised patients with stable ischaemic heart disease (IHD). The risk of bleeding of the upper gastrointestinal tract in patients with stable ischaemic heart disease is estimated by accounting for the risk factors, such as gastric and/or duodenal ulcers, history of bleeding of the upper gastrointestinal tract, long-term ingestion of anticoagulants, ingestion of non-steroidal anti-inflammatory agents and/or glucocorticosteroids for 7 days or longer. History of an abdominal aortic aneurysm and/or peripheral atherosclerosis, chronic heart failure of the II-IV functional class according to NYHA, gastric and/or duodenal erosions is herein additionally accounted for, and the risk of bleeding of the upper gastrointestinal tract (BUGT) is also estimated in a different manner depending on the age category; a corresponding score is assigned to each criterion, followed by summing the points; if the score is ≥ 4, the risk of developing bleeding is determined as high, and if the score is < 4, the risk is determined as low.

EFFECT: possibility of accurately identifying patients with a high risk of BUGT, regardless of the type of prescribed antithrombotic therapy prescribed, allowing for more effective prevention of complications of long-term antithrombotic therapy and reducing the risk of fatality.

1 cl, 1 tbl, 4 ex